01-08-2024 |
AH |
|
BIO |
Bio-Rad Laboratories, Inc. |
9,700 |
3.11 |
2.12 |
3.00 |
Bio-Rad Labs Non-GAAP EPS of $3.11 beats by $1.09, revenue of $638.48M misses by $7.92M [8/1/2024 5:16 PM] |
337.39 |
-3.86 (-1.13%) |
341.25 |
0.0 (0.00%) |
261.59 - 419.00 |
384,546 |
240,000 |
12,034 |
|
|
07-05-2024 |
AH |
|
BIO |
BioRad Laboratories |
7,965 |
2.29 |
2.04 |
0.00 |
Bio-Rad Labs Non-GAAP EPS of $2.29 beats by $0.15, revenue of $610.8M misses by $9.31M [5/7/2024 5:22 PM] |
268.00 |
-11.91 (-4.25%) |
279.91 |
0.0 (0.00%) |
261.59 - 431.79 |
224,200 |
220,000 |
12,103 |
|
|
15-02-2024 |
AH |
|
BIO |
Bio-Rad Laboratories, Inc. |
9,210 |
3.10 |
2.93 |
3.31 |
Bio-Rad Labs Non-GAAP EPS of $3.10 beats by $0.23, revenue of $681.2M misses by $5.4M [2/15/2024 4:43 PM] |
340.63 |
11.90 (3.62%) |
328.73 |
0.0 (0.00%) |
261.59 - 509.62 |
419,889 |
160,000 |
7,414 |
|
|
26-10-2023 |
AH |
|
BIO |
Bio-Rad Laboratories, Inc. |
8,830 |
2.33 |
2.87 |
2.60 |
Bio-Rad Labs Non-GAAP EPS of $2.33 misses by $0.48, revenue of $632.1M misses by $59.58M [10/26/2023 5:07 PM] |
270.63 |
-20.90 (-7.17%) |
270.00 |
-21.53 (-7.39%) |
266.19 - 509.62 |
589,724 |
280,000 |
5,597 |
|
|
03-08-2023 |
AH |
|
BIO |
Bio-Rad Laboratories, Inc. |
12,060 |
3.00 |
2.55 |
3.38 |
Bio-Rad Labs Non-GAAP EPS of $3.00 beats by $0.32, revenue of $681.11M misses by $14.72M [8/3/2023 4:47 PM] |
399.82 |
-1.98 (-0.49%) |
401.80 |
0.0 (0.00%) |
344.63 - 572.70 |
436,300 |
260,000 |
4,795 |
|
|
04-05-2023 |
AH |
4:05 PM ET (May 4) |
BIO |
Bio-Rad Laboratories, Inc. |
13,360 |
3.34 |
3.24 |
4.94 |
Bio-Rad Labs Non-GAAP EPS of $3.34 misses by $0.14, revenue of $676.8M misses by $12.48M [5/4/2023 5:28 PM] |
384.50 |
-78.11 (-16.88%) |
462.61 |
0.0 (0.00%) |
344.63 - 572.70 |
780,617 |
140,000 |
3,561 |
|
|
16-02-2023 |
AH |
4:05 PM ET (Feb 16) |
BIO |
Bio-Rad Laboratories, Inc. |
13,790 |
3.31 |
3.45 |
3.21 |
Bio-Rad Labs reports Q4 2022 results [2/16/2023 4:09 PM] |
484.42 |
28.51 (6.25%) |
455.91 |
0.0 (0.00%) |
344.63 - 651.83 |
335,895 |
140,000 |
3,047 |
|
|
27-10-2022 |
AH |
4:15 PM ET (Oct 27) |
BIO |
Bio-Rad Laboratories, Inc. |
11,550 |
2.60 |
2.59 |
3.71 |
Bio-Rad Labs Non-GAAP EPS of $2.60 misses by $0.17, revenue of $680.8M misses by $1.9M [10/27/2022 4:41 PM] |
354.50 |
-30.52 (-7.93%) |
385.02 |
0.0 (0.00%) |
350.26 - 798.97 |
480,898 |
280,000 |
10,053 |
|
|
28-07-2022 |
AH |
4:15 PM ET (Jul 28) |
BIO |
Bio-Rad Laboratories, Inc. |
15,570 |
3.38 |
2.46 |
3.54 |
Bio-Rad Labs Non-GAAP EPS of $3.38 beats by $0.67, revenue of $691.1M beats by $26.5M [7/28/2022 4:50 PM] |
563.33 |
3.47 (0.62%) |
559.86 |
0.0 (0.00%) |
462.61 - 832.70 |
210,495 |
160,000 |
1,483 |
|
|
28-04-2022 |
AH |
4:15 PM ET (Apr 28) |
BIO |
Bio-Rad Laboratories, Inc. |
14,770 |
4.94 |
2.80 |
5.21 |
Bio-Rad Labs Non-GAAP EPS of $4.94 beats by $1.83, revenue of $700.1M beats by $22.1M [4/28/2022 4:43 PM] |
513.04 |
-0.07 (-0.01%) |
513.11 |
0.0 (0.00%) |
493.37 - 832.70 |
339,050 |
180,000 |
7,954 |
|
|
10-02-2022 |
AH |
4:15 PM ET (Feb 10) |
BIO |
Bio-Rad Laboratories, Inc. |
18,490 |
3.21 |
2.87 |
4.01 |
Bio-Rad Labs Non-GAAP EPS of $3.21 beats by $0.34, revenue of $732.8M beats by $0.86M [2/10/2022 4:29 PM] |
632.66 |
7.50 (1.20%) |
630.00 |
4.83 (0.77%) |
547.22 - 832.70 |
450,773 |
240,000 |
204 |
|
|
28-10-2021 |
AH |
4:15 PM ET (Oct 28) |
BIO |
Bio-Rad Laboratories, Inc. |
23,020 |
3.71 |
2.30 |
3.00 |
Bio-Rad Labs EPS beats by $1.23, beats on revenue [10/28/2021 4:40 PM] |
797.05 |
8.23 (1.04%) |
788.82 |
0.0 (0.00%) |
507.22 - 832.70 |
114,927 |
100,000 |
1,788 |
|
|
29-07-2021 |
AH |
4:15 PM ET (Jul 29) |
BIO |
Bio-Rad Laboratories, Inc. |
20,920 |
3.54 |
1.90 |
1.61 |
Bio-Rad Labs EPS beats by $0.84, beats on revenue [7/29/2021 4:23 PM] |
741.84 |
34.71 (4.91%) |
707.13 |
0.0 (0.00%) |
472.84 - 756.51 |
251,529 |
100,000 |
3,029 |
|
|
29-04-2021 |
AH |
4:20 PM ET (Apr 29) |
BIO |
Bio-Rad Laboratories, Inc. |
19,350 |
5.21 |
2.50 |
1.91 |
Bio-Rad Labs EPS beats by $2.31, beats on revenue [4/29/2021 4:23 PM] |
630.15 |
-10.58 (-1.65%) |
640.73 |
0.0 (0.00%) |
425.00 - 689.00 |
209,724 |
120,000 |
1,848 |
|
|
11-02-2021 |
AH |
4:15 PM ET (Feb 11) |
BIO |
Bio-Rad Laboratories, Inc. |
18,750 |
4.01 |
3.10 |
2.32 |
Bio-Rad Labs EPS beats by $0.69, beats on revenue [2/11/2021 4:40 PM] |
661.22 |
17.41 (2.70%) |
650.26 |
6.45 (1.00%) |
309.38 - 689.00 |
375,565 |
253,376 |
127,152 |
|
|
29-10-2020 |
AH |
4:15 PM ET (Oct 29) |
BIO |
Bio-Rad Laboratories, Inc. |
17,260 |
3.00 |
1.85 |
1.61 |
Bio-Rad Labs EPS beats by $1.18, beats on revenue [10/29/2020 4:46 PM] |
583.84 |
15.81 (2.78%) |
568.03 |
0.0 (0.00%) |
309.38 - 598.06 |
194,323 |
137,174 |
1,915 |
|
|
30-07-2020 |
AH |
4:15 PM ET (Jul 30) |
BIO |
Bio-Rad Laboratories, Inc. |
15,470 |
1.61 |
1.30 |
1.57 |
Bio-Rad Labs EPS beats by $0.46, beats on revenue [7/30/2020 4:28 PM] |
522.90 |
-12.70 (-2.37%) |
535.00 |
-0.60 (-0.11%) |
307.40 - 540.06 |
159,952 |
166,853 |
3,688 |
|
|
06-05-2020 |
AH |
|
BIO |
Bio-Rad Laboratories, Inc. |
12,990 |
1.91 |
1.40 |
1.65 |
|
0.0 |
0.0 (0.00%) |
0.0 |
0.0 (0.00%) |
0.0 - 0.0 |
0 |
0 |
0 |
|
|